Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Bedinvetmab Injectable is dosed at 0.5–1 mg/kg SC q4 weeks (monthly) in dogs, per Plumb's Veterinary Drug Handbook, 9th Ed. Bedinvetmab Injectable is used in dogs for Osteoarthritis pain. Routes documented in dogs: SC. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Bedinvetmab Injectable in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Librela Injectable
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| SC | 0.5–1 mg/kg | q4 weeks (monthly) | Long-term monthly injections | Osteoarthritis pain | Strong | Plumb's Veterinary Drug Handbook, 9th Ed |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Caninized monoclonal antibody that binds and neutralizes nerve growth factor (NGF), reducing pain signaling in osteoarthritis.
Dogs only. Monthly injection. Injection site reactions possible. Urinary tract signs reported. Do not use in dogs with known NGF-dependent cancer. Not for acute pain.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Bedinvetmab Injectable dose range in dogs, with cited source references: SC 0.5–1 mg/kg q4 weeks (monthly). Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Bedinvetmab Injectable in dogs: SC.
Cited course lengths for Bedinvetmab Injectable in dogs include: Long-term monthly injections. Duration depends on the indication — match it to the specific dose rule in the table above.
Bedinvetmab Injectable is indicated in dogs for: Osteoarthritis pain.
These are general warnings for Bedinvetmab Injectable across species; consult the dog dosing table above for species-specific guidance. Dogs only. Monthly injection. Injection site reactions possible. Urinary tract signs reported. Do not use in dogs with known NGF-dependent cancer. Not for acute pain.
Why a species-specific page? Bedinvetmab Injectable pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.